MedPath

Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery

Phase 3
Completed
Conditions
Acute Toothache Patients Above Moderate Pain After Teeth Extraction Surgery
Interventions
Registration Number
NCT01920386
Lead Sponsor
Daewon Pharmaceutical Co., Ltd.
Brief Summary

A randomized, double-blind, active-controlled, parallel, multicenter Phase 3 study of Tramadol hydrochloride/Acetaminophen SR Tab. \& Tramadol hydrochloride/Acetaminophen Tab. in Acute Toothache Patients above Moderate Pain after Teeth Extraction Surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
240
Inclusion Criteria
  1. Adult males/Females aged over 20 years
  2. Patients with over 2 impacted wisdom teeth in the upper and lower jaws
  3. Pain VAS Value over 50 mm evaluated as 100mm VAS
  4. Subjects who voluntarily or legal guardian agreed with written consent
Exclusion Criteria
  1. Patients with severe heart disease, uncontrol hypertension, diabetes
  2. Patients who had taken a long period NSAID (eg. celecoxib, rofecoxib naproxen etc) within 3 days from the screening point
  3. Patients who had taken short-time anesthetic drugs and analgesics within 12 hours from the screening point (except short-time anesthetics before or during surgery)
  4. Patients with aspirin asthma(asthma seizure caused by NSAIDs) or medical history
  5. Patients with severe respiratory depression

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tramadol hydrochloride/Acetaminophen Tab.Tramadol hydrochloride/Acetaminophen Tab.1tab PO within 5hours from teeth extraction
Tramadol hydrochloride/Acetaminophen SR Tab.Tramadol hydrochloride/Acetaminophen SR Tab.1tab PO within 5hours from teeth extraction and then 1tab more after 6hours
Primary Outcome Measures
NameTimeMethod
SPID ; Sum of the pain intensity differences0, 0.5, 1, 2, 3, 4, 5, 6, 8, 12 hour
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath